Heron Therapeutics, Inc.
HRTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $155M | $144M | +7.4% |
| Operating income | −$2.54M | −$11.5M | +78.0% |
| Net income | −$20.2M | −$13.6M | −48.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $35.2M | $38.2M | −7.9% |
| Operating income | −$1.70M | −$4.10M | +58.5% |
| Net income | −$5.00M | −$17.5M | +71.4% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Heron Therapeutics's revenue in FY2025?
- $155M in FY2025 (Fiscal year ended Dec 31, 2025), +7.4% vs $144M a year earlier, per its 10-K filed Feb 2026.
- Was Heron Therapeutics profitable in FY2025?
- No: net income was −$20.2M and operating income −$2.54M in FY2025.
- What was Heron Therapeutics's revenue in Q3 2026?
- $35.2M (−7.9% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.